계정 가입
email 로 로그인
email 로 가입
수신함을 확인하세요
Cytochroma
About
Cytochroma is a clinical stage specialty pharmaceutical company that designs, develops and commercializes prescription products to treat
- 51 - 100
Details
- Last Funding Type
- Series B
- Last Funding Money Raised
- $3.50M
- Industries
- Biotechnology,Clinical Trials,Pharmaceutical
- Founded date
- Jan 1, 1996
- Number Of Employee
- 51 - 100
- Operating Status
- Close
Cytochroma is a clinical stage specialty pharmaceutical company that designs, develops and commercializes prescription products to treat and prevent the clinical consequences of vitamin D insufficiency and secondary hyperparathyroidism (SHPT) associated with chronic kidney disease (CKD). The Company has an advanced portfolio of new therapies designed to safely and effectively treat patients with vitamin D insufficiency and SHPT associated with Stage 3, 4 or 5 CKD. In addition, Cytochroma is developing novel therapies to treat elevated blood phosphorus levels (hyperphosphatemia) in order to improve the control of SHPT in CKD patients.
Funding Rounds
| Announced Date | Round | Money Raised | Number of Investors | Lead Investors | Post Valuation | |
|---|---|---|---|---|---|---|
| Jul 30, 2008 | Series C | $45M | 1 | — | — | Detail |
| Dec 18, 2001 | Series B | $3.50M | 3 | — | — | Detail |
| Oct 30, 2001 | Series B | $7.60M | 1 | — | — | Detail |
| Feb 1, 1999 | Series A | — | 1 | — | — | Detail |
Investors
| Investor Name | Lead Investor | Funding Round |
|---|---|---|
Canadian Medical Discoveries Fund
|
— | Series C |
|
|
— | Series B |
T2C2 Capital
|
— | Series B |
